000			01785 a2200481 4500
005			20250513190914.0
264		0	_c19990819
008			199908s 0 0 eng d
022			_a0002-8614
024	7		_a10.1111/j.1532-5415.1999.tb01291.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMiller, R A
245	0	0	_aLifelong treatment with oral DHEA sulfate does not preserve immune function, prevent disease, or improve survival in genetically heterogeneous mice. _h[electronic resource]
260			_bJournal of the American Geriatrics Society _cAug 1999
300			_a960-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdenocarcinoma _xchemically induced
650	0	4	_aAdministration, Oral
650	0	4	_aAge Factors
650	0	4	_aAnalysis of Variance
650	0	4	_aAnimals
650	0	4	_aAntibody Formation _xdrug effects
650	0	4	_aCause of Death
650	0	4	_aConfidence Intervals
650	0	4	_aDehydroepiandrosterone Sulfate _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aImmunity, Cellular _xdrug effects
650	0	4	_aImmunization
650	0	4	_aLongevity
650	0	4	_aMale
650	0	4	_aMammary Neoplasms, Animal _xchemically induced
650	0	4	_aMice
650	0	4	_aMice, Inbred Strains
650	0	4	_aPlacebos
650	0	4	_aRodent Diseases _xprevention & control
650	0	4	_aSurvival Rate
650	0	4	_aT-Lymphocyte Subsets _xdrug effects
650	0	4	_aUrologic Diseases _xchemically induced
700	1		_aChrisp, C
773	0		_tJournal of the American Geriatrics Society _gvol. 47 _gno. 8 _gp. 960-6
856	4	0	_uhttps://doi.org/10.1111/j.1532-5415.1999.tb01291.x _zAvailable from publisher's website
999			_c10401582 _d10401582